caffeic acid phenethyl ester has been researched along with Down Syndrome in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barone, E; Butterfield, DA; Caforio, M; Di Domenico, F; Folgiero, V; Locatelli, F; Pagnotta, S; Perluigi, M; Petrini, S; Pittalà, V; Salerno, L; Tramutola, A | 1 |
1 review(s) available for caffeic acid phenethyl ester and Down Syndrome
| Article | Year |
|---|---|
CAPE and its synthetic derivative VP961 restore BACH1/NRF2 axis in Down Syndrome.
Topics: Animals; Basic-Leucine Zipper Transcription Factors; Caffeic Acids; Down Syndrome; Humans; Kelch-Like ECH-Associated Protein 1; Mice; NF-E2-Related Factor 2; Oxidative Stress; Phenylethyl Alcohol | 2022 |